GoodRx reports Q4 adjusted EPS 9c, consensus 10c

Reports Q4 revenue $198.6M, consensus $199.73M. “I am excited to join GoodRx (GDRX) at such a pivotal time for both the company and healthcare system as a whole. I have spent the last thirty years in the pharmacy and medical benefit industry, and I intimately understand where there is friction and opportunity,” said Wendy Barnes, Chief Executive Officer and President of GoodRx. “I am here to help GoodRx accelerate its ability to solve the varied pain points that consumers currently face in getting medication. It’s a privilege to take on this role. I’m thrilled to be here and am optimistic about the endless opportunities we have.”